| Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms C O’Gorman, R Lucas, B Taylor International journal of molecular sciences 13 (9), 11718-11752, 2012 | 316 | 2012 |
| Modelling genetic susceptibility to multiple sclerosis with family data C O’Gorman, R Lin, J Stankovich, SA Broadley Neuroepidemiology 40 (1), 1-12, 2012 | 206 | 2012 |
| Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases N Warren, C O’Gorman, A Lehn, D Siskind Journal of Neurology, Neurosurgery & Psychiatry 88 (12), 1060-1064, 2017 | 129 | 2017 |
| Refining the psychiatric syndrome of anti‐N‐methyl‐d‐aspartate receptor encephalitis N Warren, D Siskind, C O'Gorman Acta Psychiatrica Scandinavica 138 (5), 401-408, 2018 | 125 | 2018 |
| Incidence and prevalence of NMOSD in Australia and New Zealand W Bukhari, KM Prain, P Waters, M Woodhall, MOG Cullen, L Clarke, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (8), 632-638, 2017 | 123 | 2017 |
| EEG findings in NMDA encephalitis–a systematic review L Gillinder, N Warren, G Hartel, S Dionisio, C O’Gorman Seizure 65, 20-24, 2019 | 111 | 2019 |
| Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination F Tea, JA Lopez, S Ramanathan, V Merheb, FXZ Lee, A Zou, D Pilli, ... Acta Neuropathologica Communications 7, 1-22, 2019 | 85 | 2019 |
| AQP4 antibody assay sensitivity comparison in the era of the 2015 diagnostic criteria for NMOSD K Prain, M Woodhall, A Vincent, S Ramanathan, MH Barnett, CS Bundell, ... Frontiers in neurology 10, 1028, 2019 | 78 | 2019 |
| Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases N Warren, V Grote, C O'Gorman, D Siskind Brain Stimulation 12 (2), 329-334, 2019 | 66 | 2019 |
| Ultrasound in the assessment of respiration AJ Boon, C O'Gorman Journal of Clinical Neurophysiology 33 (2), 112-119, 2016 | 54 | 2016 |
| Case–control study of blink rate in Parkinson’s disease under different conditions E Fitzpatrick, N Hohl, P Silburn, C O’Gorman, SA Broadley Journal of neurology 259, 739-744, 2012 | 52 | 2012 |
| Smoking increases the risk of multiple sclerosis in Queensland, Australia C O’Gorman, W Bukhari, A Todd, S Freeman, SA Broadley Journal of Clinical Neuroscience 21 (10), 1730-1733, 2014 | 48 | 2014 |
| Smoking and multiple sclerosis: evidence for latitudinal and temporal variation C O’Gorman, SA Broadley Journal of neurology 261, 1677-1683, 2014 | 47 | 2014 |
| Relapse patterns in NMOSD: evidence for earlier occurrence of optic neuritis and possible seasonal variation E Khalilidehkordi, L Clarke, S Arnett, W Bukhari, S Jimenez Sanchez, ... Frontiers in neurology 11, 537, 2020 | 41 | 2020 |
| Detecting fasciculations in cranial nerve innervated muscles with ultrasound in amyotrophic lateral sclerosis CM O'gorman, JG Weikamp, M Baria, L Van Den Engel‐hoek, ... Muscle & nerve 56 (6), 1072-1076, 2017 | 34 | 2017 |
| Psychiatric management of anti-NMDAR encephalitis: a cohort analysis N Warren, C O'Gorman, G McKeon, A Swayne, S Blum, D Siskind Psychological Medicine 51 (3), 435-440, 2021 | 33 | 2021 |
| Delusions in Parkinson’s disease: a systematic review of published cases N Warren, C O’Gorman, Z Hume, S Kisely, D Siskind Neuropsychology Review 28, 310-316, 2018 | 31 | 2018 |
| The clinical profile of NMOSD in Australia and New Zealand W Bukhari, L Clarke, C O’Gorman, E Khalilidehkordi, S Arnett, KM Prain, ... Journal of neurology 267, 1431-1443, 2020 | 30 | 2020 |
| Familial recurrence risks for multiple sclerosis in Australia C O'Gorman, S Freeman, BV Taylor, H Butzkueven, SA Broadley, ... Journal of Neurology, Neurosurgery & Psychiatry 82 (12), 1351-1354, 2011 | 30 | 2011 |
| Utility Of diaphragm ultrasound in myopathy CM O'Gorman, TG O'brien, AJ Boon Muscle & Nerve 55 (3), 427-429, 2017 | 29 | 2017 |
